CVS Health Corporation's board has approved a quarterly dividend of $0.665 per share. The dividend will be paid on February 2, 2026, to shareholders recorded as of January 22. This marks the 55th consecutive year the company has issued dividends, with the stock currently yielding 3.31%.
Cantor Fitzgerald has reiterated CVS Health as its preferred stock for Medicare Advantage exposure this year. The research firm stated the company remains well-positioned to benefit from a favorable regulatory environment.
Bernstein raised its price target for the stock to $87 from $86 while maintaining a Market Perform rating. The increase follows the firm's assessment of successful execution of a turnaround strategy. Bernstein views Aetna as an attractive growth engine expected to drive future performance despite challenges in the pharmacy benefit environment. The firm expects CVS to benefit from growth in pharmacy benefit managers and increased drug spending.